Study of BB-025, Alone and After BB-031, in Healthy Volunteers
NCT07202663
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
72
Enrollment
INDUSTRY
Sponsor class
Conditions
Pharmacodynamics
Pharmacokinetics
Healthy Volunteers
Interventions
DRUG:
BB-025
DRUG:
BB-031
Sponsor
Basking Biosciences, Inc.